What is the maximum recommended dose of co‑amoxiclav suspension (457 mg per 5 mL) for children, expressed in mg/kg and volume per dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose for Co-Amoxiclav 457mg/5ml Suspension in Children

The maximum recommended dose of co-amoxiclav 457mg/5ml suspension (high-dose formulation) is 90 mg/kg/day of the amoxicillin component, divided into two doses, with an absolute maximum daily dose of 4000 mg (4 g) of amoxicillin regardless of weight. 1

Weight-Based Dosing Algorithm

For the 457mg/5ml suspension (which contains 400mg amoxicillin + 57mg clavulanate per 5ml, providing a 14:1 ratio):

  • Standard high-dose regimen: 90 mg/kg/day of amoxicillin divided into two doses (every 12 hours) 1
  • Maximum single dose: 2000 mg (2 g) of amoxicillin per administration 1
  • Maximum daily dose: 4000 mg (4 g) of amoxicillin per day 1, 2

Practical Volume Calculation

To calculate the volume per dose:

  1. Multiply child's weight (kg) × 45 mg/kg = mg per dose
  2. Divide by 80 (since 5ml contains 400mg, or 80mg per ml)
  3. Result = ml per dose, given twice daily

Example: For a 20 kg child:

  • 20 kg × 45 mg/kg = 900 mg per dose
  • 900 ÷ 80 = 11.25 ml per dose
  • Give 11.25 ml twice daily (total daily dose = 1800 mg)

Indications for High-Dose Regimen

The 90 mg/kg/day regimen is specifically indicated when any of these risk factors are present: 1

  • Age < 2 years
  • Daycare attendance
  • Recent antibiotic use (within past 30 days)
  • Geographic area with > 10% penicillin-resistant S. pneumoniae
  • Moderate to severe illness
  • Incomplete Haemophilus influenzae type b vaccination
  • Concurrent purulent acute otitis media

Age-Based Alternative Dosing (Lower-Strength Formulations)

If using standard-strength suspensions rather than the 457mg/5ml formulation: 3, 1

  • < 1 year (1-12 months): 2.5 ml/kg of 125/31 suspension three times daily 3, 1
  • 1-6 years: 5 ml of 125/31 suspension three times daily 3, 1
  • 7-12 years: 5 ml of 250/62 suspension three times daily 3, 1

Critical Dosing Considerations

Maximum Dose Limits

  • Never exceed 2000 mg amoxicillin per single dose, even in children weighing > 44 kg 1
  • For children ≥ 40 kg, use adult dosing regimens rather than weight-based calculations 1, 2

Treatment Duration

  • Standard respiratory infections: 7-10 days 1
  • Pneumonia: 10 days minimum 1
  • Continue for 48-72 hours after complete symptom resolution 1

Monitoring for Response

  • Clinical improvement should be evident within 48-72 hours of starting therapy 1
  • If no improvement or worsening after 72 hours, reassess diagnosis and consider alternative pathogens or complications 1

Common Pitfalls to Avoid

  • Suspension concentration errors: The 457mg/5ml formulation is NOT the same as 125/31 or 250/62 suspensions—verify the concentration before calculating volume 1
  • Underdosing: Using standard doses (45 mg/kg/day) when high-dose therapy (90 mg/kg/day) is indicated leads to treatment failure with resistant organisms 1
  • Exceeding maximum daily dose: Even for very heavy children, never exceed 4000 mg/day total amoxicillin 1, 2
  • Inappropriate three-times-daily dosing: The 457mg/5ml high-dose formulation is designed for twice-daily administration; three-times-daily dosing would result in excessive clavulanate and increased diarrhea 1

Renal Impairment Adjustment

  • In children with established renal insufficiency, prolong the dosing interval according to creatinine clearance to avoid drug accumulation 1
  • Dose reduction is essential due to renal elimination of both amoxicillin and clavulanate 1

References

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the therapeutic dose of co-amoxiclav (amoxicillin/clavulanic acid) 457mg/5ml, given twice daily (BID), for a 5-year-old child with an upper respiratory tract infection (URTI)?
What dose in milliliters of amoxicillin/clavulanic acid suspension (457 mg/5 mL) should be administered every 12 hours for 7 days to a 2‑year‑5‑month‑old child weighing 19.5 kg?
What is the appropriate co‑amoxiclav dose for a 5‑year‑old child weighing 19.2 kg?
Can amoxyclav (amoxicillin/clavulanic acid) be given to a 1-month-old child?
What is the appropriate dosage of amoxicillin-clavulanate for a 45‑kg, 11‑year‑old male with preseptal cellulitis?
Can stopping therapeutic enoxaparin (low‑molecular‑weight heparin) 12 hours before a percutaneous liver biopsy adequately prevent bleeding?
What evidence supports that vitamin D (with calcium) supplementation reduces osteoporotic fracture risk in adults, especially those ≥65 years, with low bone mineral density or vitamin D deficiency?
What is the recommended intravenous calcium chloride dose for adults and children in acute situations such as symptomatic hypocalcemia, hyperkalemia, calcium‑channel‑blocker toxicity, or cardiac arrest?
In a patient with a stuck mechanical mitral valve prosthesis and suspected prosthetic‑valve thrombosis, what is the preferred initial treatment—intravenous thrombolysis (including dosing) versus urgent surgery—and what criteria determine the choice?
Are fluoxetine capsules and tablets therapeutically equivalent, and what are the practical differences in efficacy, side‑effects, and dosing?
Should I prescribe ondansetron 8 mg tablet twice daily before meals for an adult patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.